Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

April 17, 2018

Study Completion Date

April 17, 2018

Conditions
Diabetic Macular Edema
Interventions
DRUG

IVT aflibercept

IVT aflibercept \[2 mg/0.05 mL\]

DRUG

Sham SC

sham SC

DRUG

SC CLS-TA

CLS-TA \[4 mg/100 μL\] SC injection

Trial Locations (29)

21287

The Johns Hopkins Wilmer Eye Institute, Baltimore

28803

Western Carolina Retinal Associates, Asheville

30060

Marietta Eye Clinic, Marietta

32503

Retina Specialty Institute, Pensacola

33880

Center for Retina and Macular Disease, Winter Haven

34239

Sarasota Retina Institute, Sarasota

40509

Retina and Vitrous Associates of Kentucky, Lexington

46290

Midwest Eye Institute, Indianapolis

75231

Texas Retina Associates, Dallas

77384

Retina Consultants of Houston, The Woodlands

78503

Valley Retina Institute, P.A., McAllen

Valley Retina Institute, McAllen

78705

Austin Retina Associates, Austin

85704

Retina Centers, PC, Tucson

92260

Retina Institute of California, Palm Desert

93309

California Retina Consultants, Bakersfield

94040

Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View

97504

Oregon Retina Institute, Medford

85014-2709

Retinal Consultants of Arizona and Retinal Research Institute, Phoenix

90211-1841

Retina Vitreous Medical Group Clinical Research, Beverly Hills

92064-2526

Retina Consultants San Diego, Poway

33143-5188

MedEye Associates, Miami

30909-6440

Emory Eye Center, Augusta

21740-5940

Cumberland Valley Retina Consultants, Hagerstown

07666

Retina Associates of NJ, Teaneck

57701-7374

Black Hills Regional Eye Institute, Rapid City

79606-1224

Retina Research Institute of Texas, Abilene

76012-2505

Texas Retina Associates-Arlington, Arlington

78240-1502

Medical Center Ophthalmology Associates, San Antonio

Sponsors
All Listed Sponsors
lead

Clearside Biomedical, Inc.

INDUSTRY